Category: Diabetes/Prediabetes/Hypoglycemia

ASSESSMENT OF MODIFIABLE RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES PATIENTS- REPORT FROM PAN INDIAN DATA

Monday, Apr 8
1:00 AM – 2:00 AM

Objective :

To evaluate the association of risk factors in clinical outcomes of type 2 diabetes mellitus (T2DM) patients from large data set of pan India


Methods : A large retrospective multicentre data of T2DM patients of Apollo Sugar clinics was used for this analysis. Electronic medical records data from January 2017 to July 2018 were included in the analysis. From 11970 patients’ data modifiable risk factors: glycated hemoglobin (HbA1c >7%), hypertension (HTN; Blood pressure >140/80mmhg), low-density lipoprotein (LDL >100), and body mass index (BMI ≥25kg/m2) were evaluated. Depending on the number of associated risk factors patients were grouped into 1 risk factor, 2 risk factors, 3 risk factors, and 4 risk factors. Data were analyzed using descriptive statistics to calculate the mean (SD) and frequency (percentage).


Results : Of total 11970 patients, at baseline 4759 (40%) had HbA1c >7%, 2941 (25%) were with HTN, 926 (8%) had LDL >100, and 41% were obese. Male and female were 6113 (51%) and 5857 (49%), respectively. Patients with atleast any one of the risk factor were 4863 of these 934 (19.2%) achieved the target. Among patients with 2 risk factors (n=4822), 559 (11.6%) patients were at target, with 3 risk factors (n=859), 46 (5.4%) were at target and with 4 risk factors (n=49), 2 (4.1%) were at target. Of 2 risk factors combination, HTN+BMI 1424 (30%) and HbA1c+BMI 1395 (29%) were highest. Of 3 risk factors, majority 520 (61%) had combination of HbA1c+HTN+BMI compared to HbA1c+HTN+LDL 124 (14%), HbA1c+LDL+BMI 132 (15%) and HTN+LDL+BMI (10%).


Discussion : Our data shows nearly 40% of T2DM patients have at least one risk factor and approximately 20% of them achieved target goals. Moreover, the higher the number of risk factors associated lesser is the chance of achieving the target goal and it becomes challenging for treatment


Conclusion :

The current analysis of the association of risk factors represents the real world Pan India data. Our data show a higher percentage of patients with associated risk factors, this suggests a high attention of clinicians towards the risk factors associated in T2DM patients while recommending a prescription.

SHORT URL FUNCTION-->

Dwarakanath CS

Senior Endocrinologist
Apollo Sugar Clinic, Apollo Hospital, India

Dr. Dwarakanath C.S. is a Endocrinologist in Basavanagudi, Bangalore and has an experience of 31 years in this field. Dr. Dwarakanath C.S. practices at Surya Endocrine Diabetes Centre in Basavanagudi, Bangalore, Surya Endocrine Diabetes Centre in Nagarbhavi, Bangalore and Apollo Sugar Clinic in Bannerghatta Road, Bangalore. Completed MBBS from JJMMC, Davanagere in 1984,MD - Medicine from Mysore Medical College, Mysore in 1988 and DM - Endocrinology from All India Institutes of Medical Sciences, AIIMS, New Delhi in 1996. Member of Karnataka Medical Council and Indian Medical Association (IMA).

Usha Ayyagari

Senior Consultant Endocrinologist and Diabetes Specialist
Apollo Sugar Clinic, Apollo Hospital, India

Nil

Manikandan Rm

Endocrinologist & General Physician
Apollo Sugar Clinic, Apollo Hospital, India

Nil

Narayanan NK

Sr. Consultant Endocrinologist and Diabetes Specialist
Apollo Sugar Clinic, Apollo Hospital, India

Nil

Venkataraman S

Senior Consultant Diabetologist
Apollo Sugar Clinic, Apollo Hospital, India

Dr. S. Venkataraman is a Sr. Consultant Diabetologist practicing at Apollo Sugar Clinics, Greamsroad Chennai. He is a highly experienced diabetologist with more than 25 years of experience in treating all types of diabetes. Over the years, he has numerous publications to his credit. Apart from that, he has huge academic experience as a Professor of Diabetology and has taught in Madurai Medical College, and Rajaji Hospital, Maduria, and Madras Medical College. He received an award from IDF (International Diabetes Federation) for his paper on Pregnancy and Diabetes.

Boochandran TS

Senior Endocrinologist
Apollo Sugar Clinic, Apollo Hospital, India

Nil

Jayashree Gopal

Endocrinologist and Diabetologist
Apollo Sugar Clinic, Apollo Hospital, India

Nil

Jagat Jyoti Mukherjee

Endocrinologist
Apollo Sugar Clinic, Apollo Hospital

Nil

Surekha Tippisetty

Clinical Research Manager
Apollo Sugar Clinics Limited., India

Nil

Shashank Joshi

Senior Endocrinologist
Lilavati and Bhatia Hospital
Mumbai, Maharashtra, India

Prof Shashank R. Joshi MD, DM, FACP, FACE, FRCP
Endocrinologist, Lilavati & Bhatia Hospital
Consultant and Advisor, Apollo Sugar Clinics
President, Indian Academy of Diabetes, Past President, Endocrine Society of India
Past President, Research Society for Study of Diabetes in India(RSSDI)
Past President, All India Association for Advancement of Research in Obesity Past President, Association of Physicians of India, Emeritus Editor, JAPI
Indian Chapter Chair, AACE
He was honored by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine. He is also a recipient of the International Clinician Award, received at the 21st American Association of Clinical Endocrinologists (AACE) Annual Scientific and Clinical Congress, Philadelphia. This is an annual award given to practicing endocrinologists, outside the US